Skip to main content
Andrea Kovacs, MD, Pediatric Infectious Disease, Los Angeles, CA, Huntington Health

AndreaAKovacsMD

Pediatric Infectious Disease • Los Angeles, CA

Physician

Join to view full profile

Dr. Kovacs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kovacs' full profile

Already have an account?

Education & Training

  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterResidency, Pediatrics, 1980 - 1984
  • New York Medical College
    New York Medical CollegeClass of 1978

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1980 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

  • Fellow (FAAP) American Academy of Pediatrics
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • USC Teams with LA County Public Health to Study Impact of COVID-19 in Nation’s Most Populated County
    USC Teams with LA County Public Health to Study Impact of COVID-19 in Nation’s Most Populated CountyMarch 12th, 2021
  • New USC-L.A. County Collaboration to Track COVID-19’S Impact on Residents, Inform Public Health Strategy
    New USC-L.A. County Collaboration to Track COVID-19’S Impact on Residents, Inform Public Health StrategyMarch 10th, 2021
  • USC, LA County Public Health Team up to Study COVID's Impact
    USC, LA County Public Health Team up to Study COVID's ImpactMarch 10th, 2021
  • Join now to see all

Grant Support

  • HCV And HIV Progression In Women On HaartNational Institute Of Allergy And Infectious Diseases2008–2011
  • An Open-Label Study Of A Once Daily Dose Of Emtricitabine In Combination WithNational Center For Research Resources2005–2006
  • Prevalence Of Morphologic And Metabolic Abnormalities In HIV InfectedNational Center For Research Resources2005
  • ACTG 265: A Phase I/II Study Of Safety &Immunogenicity Of Live-AttenuatedNational Center For Research Resources2004–2005
  • HCV And Progression Of HIV And Haart Response In WomenNational Institute Of Allergy And Infectious Diseases2002–2005
  • Phase I/II Trial Of Subcutaneous IL-2 With HaartNational Center For Research Resources2004
  • Open-Label Study Of A Once Daily Dose Of EmtricitabineNational Center For Research Resources2004
  • Rolling Arm Master Protocol (PRAM) Of Novel AntiretroviralNational Center For Research Resources1999–2002
  • Increased Caloric Density Infant Formula On Growth &NutritionNational Center For Research Resources1999–2002
  • 1592U89 W/ Standard Zvd Therapy In Neonates Born To HIV WomenNational Center For Research Resources1999–2002
  • Phase II Seroconversion Of Single Dose And Two Dose Measles VaccinationNational Center For Research Resources1998–2002
  • Micronized Atovaquone And Azithromycin (At/Az) As Compared To (Tmp/Smx)National Center For Research Resources1998–2002
  • Pediatric/Maternal HIV Associated Dementia And Role Of Herpes VirusNational Center For Research Resources1996–2002
  • Pediatric LATE Outcome ProtocolNational Center For Research Resources1996–2002
  • Human Cytomegalovirus, Monokines, And Maternal Transmission Of HIVNational Center For Research Resources1996–2002
  • Zidovudine In Premature Infants Exposed To HIVNational Center For Research Resources2000
  • Intron A /Ribavirin In Pediatric PTS W Chronic HepatitisNational Center For Research Resources2000
  • ACTG 382: DMP 266 (EFAVIRENZ) And Nelfinavir In ChildrenNational Center For Research Resources2000
  • ACTG 377: 4 Antiretroviral Regimens W Protease Inhibitors, Nrtis And NnrtiNational Center For Research Resources2000
  • ACTG 366: Rad-1 Antiretroviral Management AlgorithmNational Center For Research Resources2000
  • Trial Of 2 Doses Of 2', 3'Dideoxyinosine (DDI) In Children Unresponsive To AZTNational Center For Research Resources1998–1999
  • Study Of Combined Zidovudine-Lamivudine VS DDI Monotherapy VS ZidovudineNational Center For Research Resources1998–1999
  • Safety And Immunogenicity Of A Seven Valent Pneumococcal VaccineNational Center For Research Resources1998–1999
  • Phase III Trial Of Oral Isotretinoin VS Observation In Cervical DysplasiaNational Center For Research Resources1998–1999
  • Phase I/II Evaluation Of Zidovudine VS Zidovudine And Didanosine On CD4National Center For Research Resources1998–1999
  • Pharmacokinetic And Tolerence Of Oral Ganciclovir In HIV Infected ChildrenNational Center For Research Resources1998–1999
  • Follow UP Of Women Participating In ACTG 076National Center For Research Resources1998–1999
  • Comparison Of Oral Dapsone For Prophylaxis Of Pneumocystis CariniiNational Center For Research Resources1998–1999
  • Combination Antiretrovial Therapy In Children And Adolescents With Advanced HIVNational Center For Research Resources1998–1999
  • A "Pre-Enrollment" Protocol For HIV Infected AdolescentsNational Center For Research Resources1998–1999
  • Phase III Study Of Hiv-Ig For Prevention Of Maternal Fetal HIV TransmissionNational Center For Research Resources1997–1999
  • Phase III Evaluation Of Suppressive Therapy For Recurrent Skin VesiclesNational Center For Research Resources1997–1999
  • Pediatric Pulmonary Complications Of Vertically Transmitted HIV InfectionNational Center For Research Resources1997–1999
  • Zidovudine Versus 2,3-Dideoxyinosine Versus AZT PLUS DDINational Center For Research Resources1996–1999
  • Trial To Evaluate The Safety Of AZT In Pregnant HIV Infected WomenNational Center For Research Resources1996–1999
  • Study Of Zidovudine And 2,3-Dideoxyinosine In Children With HIVNational Center For Research Resources1996–1999
  • Evaluation Of Treatment Of HIV With DideoxycytidineNational Center For Research Resources1996–1999
  • Pulmonary Complications Of Vertically Transmitted HIV InfectionNational Center For Research Resources1996
  • Maternal HIV Trans In Pregnant Women &Newborns Receiving AZTNational Center For Research Resources1996
  • High VS Low Dose Zidovudine Administered To Children W/ HIV InfectionNational Center For Research Resources1996

Professional Memberships

Hospital Affiliations

Dr. Andrea Kovacs, Dr. Andrea Kovacs, MD, Dr. A Kovacs, Dr. Andrea A Kovacs